ANDA 77958, held by Sentiss. Ketotifen Fumarate.
As of Nov 21, 2026, ANDA 77958 (Ketotifen Fumarate), held by Sentiss, was first approved by FDA on Jul 26, 2007, with 1 approved supplement and 0 published complete response letters.
Use Temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 26, 2007 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ketotifen FumarateEQ 0.025% BASE · solution/drops;ophthalmic | Ketotifen Fumarate | OTC |
| Feb 19, 2014 | Supplement 11Manufacturing | Approved | None posted |
| Jul 26, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters